Entries by aaron

Breakthrough Treatment with finerenone for Advanced Kidney Disease and Diabetes Cost-Effective

In the Netherlands, where the healthcare system grapples with the staggering burden of over one million patients combating type 2 diabetes (T2D), a significant breakthrough has emerged. A study evaluating the cost-effectiveness of integrating finerenone, a promising therapeutic addition to standard care, offers hope for patients with advanced chronic kidney disease (CKD) and T2D. The […]

SGLT2 inhibitors may slow progression of diabetic retinopathy: JAMA

SGLT2 inhibitors may lower risk of diabetic nephropathy and cut progression of diabetic retinopathy suggests a new study published in the JAMA. Diabetic nephropathy and diabetic retinopathy share many similarities in pathophysiological processes. Preclinical studies have shown that sodium-glucose cotransporter 2 inhibitors (SGLT2is) have a protective role in the risk of diabetic retinopathy. A study […]

Add on esketamine to propofol sedation may reduce hypotension in patients undergoing same-visit bidirectional endoscopy

A recent double-blind, placebo-controlled randomized clinical trial conducted across three teaching hospitals in China evaluated the efficacy of low-dose esketamine as an adjuvant to propofol-based sedation during same-visit bidirectional endoscopy. The study aimed to explore whether the addition of esketamine could potentially reduce the occurrence of adverse events such as desaturation and hypotension. This study […]

Light therapy improves sleep and psychobehavioural symptoms in patients with Alzheimer’s disease: Study

China: Light therapy significantly improves sleep and psychobehavioral symptoms and leads to relatively fewer side effects in patients with Alzheimer’s disease, a recent study published in PLOS One has revealed.  The cognitive decline associated with Alzheimer’s disease is often accompanied by sleep disturbances and psycho-behavioral symptoms including apathetic and depressive behavior, agitation and aggression. Photobiomodulation […]

Topical Atropine safe and effective for Childhood Myopia Control, Reveals Landmark Study

A comprehensive study evaluating the extended outcomes of topical atropine eye drops for childhood myopia control has shed light on its long-term safety and efficacy. The prospective, double-masked observational study, stemming from the Atropine for the Treatment of Myopia (ATOM) 1 and ATOM2 randomized clinical trials, delved into the effects of short-term atropine use during […]

Can one pause taking Ozempic to indulge in holiday festivities?

Weight loss is a biggest concern for all. An increasing number of people are choosing Ozempic as the latest solution for weight loss and now many of them are considering whether to pause the medication to more comfortably enjoy food-filled holiday festivities. But is that advisable and safe to do? According to the U.S. Food […]

Synokem Pharmaceutical Gets CDSCO Panel Nod To study Antidiabetic FDC Drug

New Delhi: With the condition of including more government sites distributed geographically, Synokem Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the Phase IV clinical trial of the fixed-dose combination of the antidiabetic drug Linagliptin plus Metformin Hydrochloride film-coated bilayered tablet. This […]